Binzhou People's Hospital
12
5
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography
Role: collaborator
An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound
Role: collaborator
Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China
Role: collaborator
An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
Role: collaborator
Second-line Treatment of Metastatic Colorectal Cancer
Role: collaborator
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
Role: collaborator
China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）
Role: collaborator
Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Role: collaborator
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Role: collaborator
Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment
Role: collaborator
Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy
Role: collaborator
Tailored Bowel Preparation According to Bristol Stool Form Scale
Role: collaborator
All 12 trials loaded